Ask AI
Back Back
Meningococcal Vaccination in Children and Adolescents
Busting the Myths About Meningococcal Vaccination in Children and Adolescents

Released: March 26, 2026

Jana Shaw
Jana Shaw, MD, MPH, MS, FAAP, FPIDS
Activity Information

Activity

Progress
1
Course Completed
Continue
Key Takeaways
  • Many patients and caregivers are not up-to-date on the meningococcal vaccine doses and boosters required for full protection.
  • Pediatric and family medicine NPs and PAs are well-positioned to use reminder systems and follow-up strategies to encourage adherence to the appropriate vaccine schedule.

Invasive meningococcal disease (IMD) remains a rare but potentially devastating illness in children and adolescents, with rapid progression, high morbidity, and significant mortality. Despite the availability of safe and effective vaccines, uptake among adolescents is suboptimal, and disparities in coverage persist.

Nurse practitioners (NPs) and physician associates (PAs) are at the forefront of adolescent care and play a pivotal role in bridging these gaps, offering evidence-based counseling, administering vaccines, and addressing barriers to immunization.

Understanding the Risk of IMD
Although some parents and caregivers believe healthy adolescents are unlikely to experience severe disease, certain risk factors, including underlying medical conditions, immune deficiencies, or high-risk behaviors, significantly increase vulnerability.

For example, college students, particularly new freshmen living in dormitories, face a higher risk for IMD due to close living quarters and increased opportunity for bacterial spread through shared food and drinks.

Clinical presentations can be subtle, but the disease can progress rapidly if not promptly detected and treated with appropriate antibiotics. Death or permanent disability can occur in as little as 24-48 hours, and survivors may face long-term physical, social, and emotional consequences, highlighting the importance of prevention through vaccination.

Achieving Full Protective Efficacy
Despite the potentially grave consequences of IMD, many parents, caregivers, and even some healthcare professionals (HCPs) are not up-to-date on which vaccines are necessary for full protection. Completing the full vaccination series is crucial, as incomplete dosing leaves adolescents at risk. NPs and PAs should use reminder systems and follow-up strategies to encourage adherence to the appropriate vaccine schedule.

High-risk children, such as those with asplenia or complement deficiencies, may require an adjusted dosing schedule with additional booster doses, and should not be excluded from primary care vaccination efforts. Although specialty clinics can play a role in vaccine uptake, primary care providers share responsibility for ensuring timely immunization, with pentavalent vaccines offering a practical solution to streamline care.

Shared Clinical Decision-making With Adolescents
College-bound adolescents are a key population for meningococcal vaccination, and it is important that they be fully vaccinated before heading off to school. However, the conversation about MenB vaccination should also extend beyond adolescents planning to attend college.

Shared clinical decision-making frameworks are an important way to reach adolescents who are just beginning to learn how to take charge of their own healthcare choices. These approaches can help NPs and PAs guide discussions with all eligible patients and caregivers, emphasizing informed, patient-centered choices. As recommendations evolve, HCPs must be prepared to engage every eligible adolescent and their families in meaningful discussions about vaccine safety, effectiveness, and disease prevention. 

Parental hesitancy is not static, and repeated offers of vaccination can influence acceptance. HCP recommendation is the strongest predictor of uptake. Using motivational interviewing techniques, addressing concerns without judgment, and including adolescents in the discussion can increase vaccine confidence and completion rates.

The NP and PA Role
Individual NPs and PAs can make a significant impact on vaccination coverage. By dispelling myths, providing evidence-based education, advocating for vaccine equity, and engaging both patients and communities, HCPs contribute meaningfully to closing immunization gaps. Every patient encounter is an opportunity to prevent disease, protect health, and build trust in vaccines.

Ultimately, enhancing meningococcal vaccination among children and adolescents requires a combination of accurate information, strong HCP recommendations, and patient-centered communication strategies. NPs and PAs are uniquely positioned to lead these efforts, ensuring that adolescents are informed, protected, and empowered to participate in their healthcare decisions.

To learn more about risk factors for IMD, including the latest data on vaccines and recommendations, join me and my colleague Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP, at our live, virtual forum, specifically for pediatric and family medicine NPs and PAs.

Your Thoughts
How do you approach the topic of vaccination with patients and their caregivers? What resources or education would make initiating these discussions easier? Leave a comment to join the discussion!

Continue